If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

NGM Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 38.10%

Insider Buying (Last 12 Months): $20,639,580.97

Insider Selling (Last 12 Months): $438,172.30

NGM Biopharmaceuticals Insider Trading History Chart

NGM Biopharmaceuticals Share Price & Price History

^$3.94

▲ +0.08 (2.07%)

As of 03/21/2023 05:00 PM ET

Days: 30 | 90 | 365

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

NGM Biopharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/30/2023	Group L P Column	Director	Buy	7,542	$5.00	$37,710.00	750,501
1/23/2023	Group L P Column	Director	Buy	9,900	$5.00	$49,500.00	742,959
1/19/2023	Group L P Column	Director	Buy	37,639	$5.00	$188,195.00	732,559
1/17/2023	Jin-Long Chen	Insider	Sell	85,082	$5.15	$438,172.30	908,893
1/12/2023	Group L P Column	Director	Buy	5,378	$4.95	$26,621.10	694,920
1/10/2023	Group L P Column	Director	Buy	100,070	$4.84	$484,338.80	480,542
12/12/2022	Group L P Column	Director	Buy	300	$4.98	$1,494.00	380,472
11/21/2022	Group L P Column	Director	Buy	35,997	$5.00	$179,985.00	375,842
11/3/2022	Group L P Column	Director	Buy	104,090	$4.99	$519,409.10	304,787
10/27/2022	David V Goeddel	Director	Buy	76,877	$4.86	$373,622.22	200,697
10/25/2022	Group L P Column	Director	Buy	51,046	$4.75	$242,468.50	51,046
10/17/2022	David V Goeddel	Director	Buy	50,000	$3.18	$159,000.00	130,000
6/9/2022	Group L P Column	Director	Buy	984,161	$13.50	$13,286,173.50	2,650,177
6/2/2022	Group L P Column	Director	Buy	34,200	$13.03	$445,626.00	1,698,493
5/31/2022	Group L P Column	Director	Buy	61,806	$13.47	$832,526.82	1,576,458
5/26/2022	Group L P Column	Director	Buy	20,201	$13.49	$272,511.49	1,514,071
5/24/2022	Group L P Column	Director	Buy	17,828	$13.37	$238,360.36	1,452,674
5/19/2022	Group L P Column	Director	Buy	20,666	$13.25	$273,824.50	1,417,028
5/17/2022	Group L P Column	Director	Buy	89,049	$13.42	$1,195,037.58	1,336,461
5/11/2022	Group L P Column	Director	Buy	83,175	$11.25	$935,718.75	1,012,753
5/9/2022	Group L P Column	Director	Buy	83,175	$10.79	$897,458.25	902,090
12/6/2021	Jin-Long Chen	Insider	Sell	15,000	$18.21	$273,150.00
11/18/2021	David J. Woodhouse	CEO	Sell	15,000	$20.02	$300,300.00
11/15/2021	Jin-Long Chen	Insider	Sell	30,000	$19.73	$591,900.00
10/11/2021	Jin-Long Chen	Insider	Sell	15,000	$20.41	$306,150.00
10/5/2021	Hsiao D. Lieu	SVP	Sell	2,000	$22.00	$44,000.00
9/13/2021	Jin-Long Chen	Insider	Sell	15,000	$26.03	$390,450.00
8/9/2021	Jin-Long Chen	Insider	Sell	15,000	$24.46	$366,900.00
4/12/2021	Jin-Long Chen	Insider	Sell	25,000	$24.65	$616,250.00	945,005
3/1/2021	Jin-Long Chen	Insider	Sell	25,000	$26.66	$666,500.00	970,005
1/4/2021	Jin-Long Chen	Insider	Sell	25,000	$29.28	$732,000.00	870,375
12/14/2020	Jin-Long Chen	Insider	Sell	25,000	$28.01	$700,250.00	908,879
10/12/2020	Jin-Long Chen	Insider	Sell	25,000	$17.02	$425,500.00	945,005
9/1/2020	Group L P Column	Director	Buy	36,494	$17.64	$643,754.16
9/1/2020	Jin-Long Chen	Insider	Sell	25,000	$17.83	$445,750.00	977,618
8/27/2020	Group L P Column	Director	Buy	36,359	$17.79	$646,826.61
8/24/2020	Group L P Column	Director	Buy	11,024	$17.96	$197,991.04
8/21/2020	Group L P Column	Director	Buy	7,321	$17.97	$131,558.37
8/17/2020	Group L P Column	Director	Buy	6,425	$17.89	$114,943.25
8/13/2020	Group L P Column	Director	Buy	19,895	$17.89	$355,921.55
7/30/2020	Group L P Column	Director	Buy	732	$17.99	$13,168.68
7/27/2020	Group L P Column	Director	Buy	3,834	$17.99	$68,973.66
7/24/2020	Group L P Column	Director	Buy	68,749	$17.93	$1,232,669.57
7/22/2020	Group L P Column	Director	Buy	193	$18.00	$3,474.00
7/1/2020	Jin-Long Chen	Insider	Sell	25,000	$18.91	$472,750.00	1,027,268
6/15/2020	Jin-Long Chen	Insider	Sell	25,000	$21.65	$541,250.00
5/15/2020	Hsiao D. Lieu	SVP	Sell	1,562	$22.00	$34,364.00
4/7/2020	Group L P Column	Major Shareholder	Buy	138,315	$14.19	$1,962,689.85
4/7/2020	Peter Svennilson	Director	Buy	123,728	$14.38	$1,779,208.64	20,000
4/2/2020	Group L P Column	Major Shareholder	Buy	250,984	$12.78	$3,207,575.52
4/2/2020	Peter Svennilson	Director	Buy	14,850	$12.40	$184,140.00	20,000
3/31/2020	Peter Svennilson	Director	Buy	118,067	$12.53	$1,479,379.51	20,000
3/25/2020	Group L P Column	Major Shareholder	Buy	301,180	$13.33	$4,014,729.40
3/25/2020	Peter Svennilson	Director	Buy	2,416	$12.49	$30,175.84	20,000
3/23/2020	Peter Svennilson	Director	Buy	170,387	$11.63	$1,981,600.81	20,000
3/20/2020	Group L P Column	Major Shareholder	Buy	143,082	$11.77	$1,684,075.14
3/19/2020	Peter Svennilson	Director	Buy	148,464	$11.59	$1,720,697.76	20,000

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

SEC Filings (Institutional Ownership Changes) for NGM Biopharmaceuticals (NASDAQ:NGM)

64.55% of NGM Biopharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

NGM Biopharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/16/2023	Alliancebernstein L.P.	59,500	$0.30M	0.0%	+54.1%	0.073%
2/15/2023	Public Employees Retirement System of Ohio	49,424	$0.25M	0.0%	N/A	0.060%
2/15/2023	Jane Street Group LLC	31,724	$0.16M	0.0%	N/A	0.039%
2/15/2023	Jasper Ridge Partners L.P.	348,250	$1.75M	0.1%	+9.3%	0.426%
2/15/2023	State of Wisconsin Investment Board	153,218	$0.77M	0.0%	+394.5%	0.187%
2/15/2023	Susquehanna Fundamental Investments LLC	43,957	$0.22M	0.0%	N/A	0.054%
2/15/2023	Schonfeld Strategic Advisors LLC	30,900	$0.16M	0.0%	-57.3%	0.038%
2/15/2023	Squarepoint Ops LLC	98,767	$0.50M	0.0%	+281.1%	0.121%
2/15/2023	Millennium Management LLC	458,230	$2.30M	0.0%	+98.5%	0.561%
2/15/2023	Morgan Stanley	662,033	$3.32M	0.0%	+21.0%	0.810%
2/15/2023	Man Group plc	137,544	$0.69M	0.0%	+276.8%	0.168%
2/15/2023	Algert Global LLC	73,890	$0.37M	0.0%	-5.1%	0.090%
2/15/2023	Alps Advisors Inc.	55,520	$0.28M	0.0%	N/A	0.068%
2/15/2023	AQR Capital Management LLC	76,477	$0.38M	0.0%	N/A	0.094%
2/14/2023	PDT Partners LLC	104,383	$0.52M	0.1%	+204.6%	0.128%
2/14/2023	Price T Rowe Associates Inc. MD	40,187	$0.20M	0.0%	+18.4%	0.049%
2/14/2023	Putnam Investments LLC	30,138	$0.15M	0.0%	-18.3%	0.037%
2/14/2023	Parkwood LLC	68,314	$0.34M	0.1%	+54.2%	0.084%
2/14/2023	Alpine Global Management LLC	17,765	$89K	0.0%	N/A	0.022%
2/14/2023	Two Sigma Investments LP	279,190	$1.40M	0.0%	+7.4%	0.342%
2/14/2023	EcoR1 Capital LLC	6,435,518	$32.31M	1.0%	+1,089.3%	7.874%
2/13/2023	Charles Schwab Investment Management Inc.	327,974	$1.65M	0.0%	+4.3%	0.401%
2/13/2023	Deutsche Bank AG	243,855	$1.22M	0.0%	-7.2%	0.298%
2/13/2023	Panagora Asset Management Inc.	155,922	$0.78M	0.0%	+8.2%	0.191%
2/13/2023	Barclays PLC	69,904	$0.35M	0.0%	+59.3%	0.086%
2/13/2023	Renaissance Technologies LLC	343,500	$1.72M	0.0%	+25.3%	0.420%
2/13/2023	ExodusPoint Capital Management LP	107,214	$0.54M	0.0%	+103.6%	0.131%
2/13/2023	Credit Suisse AG	34,594	$0.17M	0.0%	+24.8%	0.042%
2/13/2023	Geode Capital Management LLC	748,724	$3.76M	0.0%	+1.5%	0.916%
2/13/2023	GSA Capital Partners LLP	129,279	$0.65M	0.1%	+1,069.0%	0.158%
2/13/2023	JPMorgan Chase & Co.	566,539	$2.85M	0.0%	+6.1%	0.693%
2/13/2023	Cornercap Investment Counsel Inc.	46,062	$0.23M	0.0%	+300.6%	0.056%
2/10/2023	Bank of America Corp DE	54,507	$0.27M	0.0%	+33.8%	0.067%
2/10/2023	Connor Clark & Lunn Investment Management Ltd.	154,410	$0.78M	0.0%	+39.5%	0.189%
2/10/2023	Franklin Resources Inc.	16,500	$83K	0.0%	N/A	0.020%
2/9/2023	Landscape Capital Management L.L.C.	21,492	$0.11M	0.0%	N/A	0.026%
2/9/2023	Dimensional Fund Advisors LP	547,865	$2.75M	0.0%	-30.5%	0.670%
2/9/2023	Principal Financial Group Inc.	18,703	$94K	0.0%	+33.2%	0.023%
2/8/2023	Raymond James Financial Services Advisors Inc.	53,427	$0.27M	0.0%	-37.1%	0.065%
2/8/2023	Raymond James & Associates	28,273	$0.14M	0.0%	-70.5%	0.035%
2/8/2023	Russell Investments Group Ltd.	45,686	$0.23M	0.0%	+87.8%	0.056%
2/7/2023	Fox Run Management L.L.C.	45,798	$0.23M	0.1%	+300.1%	0.056%
2/2/2023	SG Americas Securities LLC	14,374	$72K	0.0%	+35.1%	0.018%
2/1/2023	Zurcher Kantonalbank Zurich Cantonalbank	11,516	$58K	0.0%	+43.2%	0.014%
1/17/2023	Diversified Trust Co	12,885	$65K	0.0%	N/A	0.016%
1/12/2023	Hennion & Walsh Asset Management Inc.	58,869	$0.30M	0.0%	-66.4%	0.072%
12/8/2022	Bank of New York Mellon Corp	150,629	$1.97M	0.0%	+15.2%	0.184%
11/16/2022	BNP Paribas Arbitrage SNC	17,092	$0.22M	0.0%	+13.4%	0.021%
11/15/2022	State Street Corp	855,575	$11.19M	0.0%	+11.0%	1.047%
11/15/2022	Jacobs Levy Equity Management Inc.	68,649	$0.90M	0.0%	N/A	0.084%
11/15/2022	Algert Global LLC	77,840	$1.02M	0.1%	+8.2%	0.095%
11/15/2022	Two Sigma Advisers LP	286,700	$3.75M	0.0%	+45.5%	0.351%
11/15/2022	Two Sigma Investments LP	259,940	$3.40M	0.0%	+53.9%	0.318%
11/15/2022	Trexquant Investment LP	35,245	$0.46M	0.0%	N/A	0.043%
11/15/2022	UBS Asset Management Americas Inc.	30,767	$0.40M	0.0%	-11.2%	0.038%
11/15/2022	Vanguard Group Inc.	3,899,297	$51M	0.0%	+14.6%	4.771%
11/15/2022	Price T Rowe Associates Inc. MD	33,945	$0.45M	0.0%	+66.1%	0.042%
11/15/2022	Logos Global Management LP	850,000	$11.12M	1.4%	N/A	1.040%
11/15/2022	First Light Asset Management LLC	955,505	$12.50M	1.3%	-15.9%	1.169%
11/15/2022	Bank of New York Mellon Corp	150,629	$1.97M	0.0%	+15.2%	0.184%
11/15/2022	BlackRock Inc.	4,066,577	$53.19M	0.0%	+5.0%	4.976%
11/14/2022	Royal Bank of Canada	3,195	$41K	0.0%	+353.2%	0.004%
11/14/2022	Point72 Asset Management L.P.	362,900	$4.75M	0.0%	-72.5%	0.444%
11/14/2022	Cubist Systematic Strategies LLC	74,998	$0.98M	0.0%	-58.8%	0.092%
11/14/2022	PDT Partners LLC	34,267	$0.45M	0.1%	N/A	0.042%
11/14/2022	Renaissance Technologies LLC	274,200	$3.59M	0.0%	-19.0%	0.336%
11/14/2022	Nuveen Asset Management LLC	738,810	$9.66M	0.0%	+38.0%	0.904%
11/14/2022	Parkwood LLC	44,314	$0.58M	0.1%	N/A	0.054%
11/14/2022	AXA S.A.	405,683	$5.31M	0.0%	+0.8%	0.496%
11/14/2022	Rubric Capital Management LP	877,161	$11.47M	0.6%	+10.0%	1.073%
11/14/2022	Hsbc Holdings PLC	12,757	$0.17M	0.0%	+23.6%	0.016%
11/14/2022	Hennion & Walsh Asset Management Inc.	175,183	$2.29M	0.2%	+3.5%	0.214%
11/10/2022	Connor Clark & Lunn Investment Management Ltd.	110,699	$1.45M	0.0%	+207.0%	0.135%
11/10/2022	ExodusPoint Capital Management LP	52,672	$0.69M	0.0%	N/A	0.064%
11/10/2022	Dimensional Fund Advisors LP	787,808	$10.30M	0.0%	+21.8%	0.964%
11/10/2022	Tower Research Capital LLC TRC	5,674	$74K	0.0%	+154.1%	0.007%
11/8/2022	New York State Common Retirement Fund	26,462	$0.35M	0.0%	+16.5%	0.033%
11/7/2022	Jump Financial LLC	31,400	$0.41M	0.0%	+9.8%	0.039%
11/4/2022	Russell Investments Group Ltd.	24,332	$0.32M	0.0%	+94.7%	0.030%
11/3/2022	Barclays PLC	43,895	$0.58M	0.0%	+72.6%	0.055%
11/2/2022	Los Angeles Capital Management LLC	11,919	$0.16M	0.0%	N/A	0.015%
11/1/2022	Jennison Associates LLC	122,430	$1.60M	0.0%	N/A	0.152%
10/28/2022	Silverarc Capital Management LLC	94,517	$1.24M	0.4%	+7.0%	0.118%
10/27/2022	Strs Ohio	45,100	$0.59M	0.0%	-4.4%	0.056%
10/25/2022	Raymond James & Associates	95,686	$1.25M	0.0%	+34.8%	0.119%
10/25/2022	Raymond James Financial Services Advisors Inc.	84,886	$1.11M	0.0%	+35.4%	0.106%
9/2/2022	Amundi	7,407	$0.12M	0.0%	N/A	0.009%
8/18/2022	Goldman Sachs Group Inc.	172,206	$2.21M	0.0%	+5.1%	0.214%
8/16/2022	Woodline Partners LP	134,188	$1.72M	0.0%	-71.5%	0.167%
8/16/2022	Price T Rowe Associates Inc. MD	20,440	$0.26M	0.0%	+7.5%	0.025%
8/15/2022	State Street Corp	770,442	$9.88M	0.0%	+11.4%	0.959%
8/15/2022	Cubist Systematic Strategies LLC	181,986	$2.33M	0.0%	+124.2%	0.226%
8/15/2022	Point72 Asset Management L.P.	1,320,662	$16.93M	0.1%	-58.9%	1.643%
8/15/2022	Millennium Management LLC	441,475	$5.66M	0.0%	+5.8%	0.549%
8/15/2022	Partners Group Holding AG	177,255	$2.27M	0.1%	N/A	0.221%
8/15/2022	UBS Asset Management Americas Inc.	34,663	$0.44M	0.0%	+86.1%	0.043%
8/13/2022	Quantbot Technologies LP	5,932	$76K	0.0%	+315.7%	0.007%
8/13/2022	Renaissance Technologies LLC	338,368	$4.34M	0.0%	+117.3%	0.421%
8/13/2022	American International Group Inc.	18,351	$0.24M	0.0%	+17.3%	0.023%
8/13/2022	Column Group LLC	18,136,735	$232.51M	49.5%	+11.6%	22.568%

Data available starting January 2016

NGM Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for cardio-metabolic, liver, oncologic, and ophthalmic diseases. Its lead product candidate, aldafermin, is designed for the treatment of patients with non-alcoholic steatohepatitis, with liver fibrosis stage 2, 3, or 4. The company was founded by Jin-Long Chen on December 20, 2007 and is headquartered in South San Francisco, CA.

Today's Range

Now: $3.94

$3.89

$4.00

50 Day Range

MA: $4.74

$3.72

$5.40

52 Week Range

Now: $3.94

$2.92

$18.25

Volume

517,936 shs

Average Volume

342,756 shs

Market Capitalization

$323.28 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.23

Who are the company insiders with the largest holdings of NGM Biopharmaceuticals?: NGM Biopharmaceuticals' top insider shareholders include:
Group L P Column (Director)
Jin-Long Chen (Insider)
David V Goeddel (Director)
David J Woodhouse (CEO)
Hsiao D Lieu (SVP)
Learn More about top insider investors at NGM Biopharmaceuticals.
Who are the major institutional investors of NGM Biopharmaceuticals?: NGM Biopharmaceuticals' top institutional shareholders include:
EcoR1 Capital LLC — 7.87%
Geode Capital Management LLC — 0.92%
Morgan Stanley — 0.81%
JPMorgan Chase & Co. — 0.69%
Dimensional Fund Advisors LP — 0.67%
Millennium Management LLC — 0.56%
Learn More about top institutional investors of NGM Biopharmaceuticals stock.
Which major investors are selling NGM Biopharmaceuticals stock?: During the last quarter, NGM stock was sold by these institutional investors:
Dimensional Fund Advisors LP
Hennion & Walsh Asset Management Inc.
Raymond James & Associates
Schonfeld Strategic Advisors LLC
Raymond James Financial Services Advisors Inc.
Deutsche Bank AG
Putnam Investments LLC
Algert Global LLC
Which major investors are buying NGM Biopharmaceuticals stock?: During the last quarter, NGM stock was acquired by institutional investors including:
EcoR1 Capital LLC
Millennium Management LLC
State of Wisconsin Investment Board
GSA Capital Partners LLP
Morgan Stanley
Man Group plc
AQR Capital Management LLC
Squarepoint Ops LLC
Within the last year, these company insiders have bought NGM Biopharmaceuticals stock:
Group L P Column (Director)
Jin-Long Chen (Insider)
Learn More investors buying NGM Biopharmaceuticals stock.

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

NGM Insider Trading

NGM Biopharmaceuticals Insider Trading History Chart

NGM Biopharmaceuticals Share Price & Price History

NGM Biopharmaceuticals Insider Trading History

SEC Filings (Institutional Ownership Changes) for NGM Biopharmaceuticals (NASDAQ:NGM)

Institutional Buying and Selling by Quarter

NGM Biopharmaceuticals Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of NGM Biopharmaceuticals?

Who are the major institutional investors of NGM Biopharmaceuticals?

Which major investors are selling NGM Biopharmaceuticals stock?

Which major investors are buying NGM Biopharmaceuticals stock?